A controlled trial of nebulized salbutamol and adrenaline in acute severe asthma. 1995

F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
Service de Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia.

OBJECTIVE To compare efficacy and safety of nebulisation of adrenaline (2 mg over 10 min) and salbutamol (5 mg over 10 min) in acute severe asthma. METHODS Prospective randomized and double blind study. METHODS Intensive care unit of a University teaching hospital. METHODS 22 asthmatic patients presenting to the emergency room with acute severe asthma. METHODS Patients were randomly assigned to receive either adrenaline (n = 11) or salbutamol (n = 11) via a nebulizer. Additional treatment comprised hydrocortisone hemisuccinate (100 mg) and supplemental oxygen (71/min). The efficacy and safety of both drugs were evaluated at 20 and 40 min. RESULTS A statistically significant increase in the Peak Expiratory Flow (PEF) was achieved at the 20th min in both groups (from 85 +/- 38 l/min to 120 +/- 45 l/min; p < 0.001; and from 107 +/- 28 l/min to 145 +/- 19 l/min; p < 0.001; in adrenaline group and salbutamol group respectively). With both drugs, PEF further increased at 40 min to a level that was statistically significant when compared to the 20 min evaluation. The magnitude of the absolute variation in PEF was similar with both drugs. Both drugs induced a significant decrease in heart rate, respiratory frequency and PaCO2 while the increase of PaO2/FIO2 ratio was not significant. The decrease of respiratory frequency at 40 min was more important with salbutamol (p = 0.03). No side effects were recorded in both groups. CONCLUSIONS After a single dose, nebulized adrenaline (2 mg) proved as effective and safe as salbutamol (5 mg) in acute severe asthma.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010366 Peak Expiratory Flow Rate Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR. Expiratory Peak Flow Rate,Flow Rate, Peak Expiratory,PEFR
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001784 Blood Gas Analysis Measurement of oxygen and carbon dioxide in the blood. Analysis, Blood Gas,Analyses, Blood Gas,Blood Gas Analyses,Gas Analyses, Blood,Gas Analysis, Blood
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D005260 Female Females

Related Publications

F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
July 1984, Archives of disease in childhood,
F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
November 2002, Annales francaises d'anesthesie et de reanimation,
F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
August 1998, The European respiratory journal,
F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
October 1987, European journal of respiratory diseases,
F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
December 1986, The Ceylon medical journal,
F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
April 2003, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
April 1983, British journal of diseases of the chest,
F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
June 2004, Journal of critical care,
F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
February 1999, The European respiratory journal,
F Abroug, and S Nouira, and A Bchir, and R Boujdaria, and S Elatrous, and S Bouchoucha
November 1976, The Medical journal of Australia,
Copied contents to your clipboard!